Details of the Drug Formulations

General Information of Drug (ID: DM07K2I)

Drug Name
Eprosartan Drug Info
Synonyms
133040-01-4; Teveten; F-108566; F 108566; UNII-2KH13Z0S0Y; (E)-4-((2-Butyl-5-(2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl)-1H-imidazol-1-yl)methyl)benzoic acid; (E)-2-Butyl-1-(p-carboxybenzyl)-alpha-2-thenylimidazole-5-acrylic acid; CHEMBL813; SK-108566; 2KH13Z0S0Y; CHEBI:4814; 4-({2-butyl-5-[(1E)-2-carboxy-3-(2-thienyl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; (E)-3-[2-n-butyl-1-{(4-carboxyphenyl)methyl}-1H-imidazol-5-yl]-2-(2-thienyl)methyl-2-propenoic acid; SK&F 108566; SKF-108566; Teveten (TN); Eprosartan (USAN/INN); Eprosartan [USAN:BAN:INN]; SK&F-108566; (4-carboxybenzyl)imidazole-5-acrylic acid; (E)-alpha{[2-butyl-1-[(4-carboxyphenyl)methyl]-1H-imidazole-5-yl]methylene}-2-thiopheneproprionic acid; 4-({2-butyl-5-[(1E)-2-carboxy-3-(thiophen-2-yl)prop-1-en-1-yl]-1H-imidazol-1-yl}methyl)benzoic acid; 4-[[2-butyl-5-[(E)-3-hydroxy-3-oxo-2-(thiophen-2-ylmethyl)prop-1-enyl]imidazol-1-yl]methyl]benzoic acid; [3H]eprosartan
Indication
Disease Entry ICD 11 Status REF
Hypertension BA00-BA04 Approved [1]
Therapeutic Class
Antihypertensive Agents
Cross-matching ID
PubChem CID
5281037
ChEBI ID
CHEBI:4814
CAS Number
133040-01-4
TTD ID
D0T7US
VARIDT ID
DR01208
ACDINA ID
D00236

Full List of Drug Formulations Containing This Drug

Eprosartan 400 mg tablet
Company Formulation ID FDA Description
Mylan Pharamceuticals F07332 Lactose monohydrate; Magnesium stearate; Ammonia; Ferric oxide red; Ferric oxide yellow; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Crospovidone; Polysorbate 80; Povidone; Silicon dioxide; Cellulose, microcrystalline; Hydroxypropyl cellulose; Hypromelloses; Polyethylene glycol; Shellac; Starch, corn
AbbVie F07333 Lactose monohydrate; Magnesium stearate; Ferric oxide red; Ferric oxide yellow; Titanium dioxide; Croscarmellose sodium; Polysorbate 80; Cellulose, microcrystalline; Hypromelloses; Polyethylene glycols; Starch, corn
------------------------------------------------------------------------------------
Eprosartan Mesylate eq 400mg base tablet
Company Formulation ID FDA Description
Abbvie F23443 Croscarmellose Sodium; Hypromellose; Iron Oxide Red; Iron Oxide Yellow; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Polyethylene Glycol; Polysorbate 80; Pregelatinized Starch; Titanium Dioxide
Abbvie F23445 Microcrystalline Cellulose; Lactose Monohydrate; Pregelatinized Starch; Crospovidone; Magnesium Stearate; Purified Water
------------------------------------------------------------------------------------
Eprosartan Mesylate eq 600mg base tablet
Company Formulation ID FDA Description
Abbvie F23444 Crospovidone; Hypromellose; Lactose Monohydrate; Magnesium Stearate; Microcrystalline Cellulose; Polyethylene Glycol; Polysorbate 80; Pregelatinized Starch; Titanium Dioxide
------------------------------------------------------------------------------------
Eprosartan 600 mg tablet
Company Formulation ID FDA Description
Mylan Pharamceuticals F07334 Lactose monohydrate; Magnesium stearate; Ammonia; Ferrosoferric oxide; Propylene glycol; Titanium dioxide; Polysorbate 80; Silicon dioxide; Crospovidone, unspecified; Hydroxypropyl cellulose, unspecified; Hypromellose, unspecified; Microcrystalline cellulose; Polyethylene glycol, unspecified; Povidone, unspecified; Shellac; Starch, corn
AbbVie F07335 Lactose monohydrate; Magnesium stearate; Titanium dioxide; Crospovidone; Polysorbate 80; Cellulose, microcrystalline; Polyethylene glycols; Starch, corn
------------------------------------------------------------------------------------

References

1 URL: http://www.guidetopharmacology.org Nucleic Acids Res. 2015 Oct 12. pii: gkv1037. The IUPHAR/BPS Guide to PHARMACOLOGY in 2016: towards curated quantitative interactions between 1300 protein targets and 6000 ligands. (Ligand id: 588).